Found 0 matching trials
Adaptive Mobile Interventions to Reduce Cancer Risk Behaviors NA Tobacco use remains the leading cause of preventable death, causing over 40...
Show More Location
Johns Hopkins Bloomberg School of Public Health
Learn More & Join Trial
Safety and Efficacy of SHR2554 Combined With Other Antitumor Therapies in Gastric or Gastro-oesophageal Junction Adenocarcinoma PHASE2 This is a multicenter, phase 2, open label study to evaluate safety, tolera...
Show More Location
Harbin Medical University Cancer Hospital
Learn More & Join Trial
PATHS-UP Health Behavior Self-monitoring Mobile App for Adolescents NA Hispanic adolescents in the U.S. are disproportionately burdened by type 2 ...
Show More Location
Children's Nutrition Research Center
Learn More & Join Trial
Delayed Tolerance Through Mixed Chimerism PHASE1 This study will examine the safety and effectiveness of a bone marrow trans...
Show More Status
Active Not Recruiting
Location
Massachusetts General Hospital
Learn More & Join Trial
Functional Connectivity as a Biomarker of rTMS PHASE1 Background:
Traumatic brain injury (TBI) damages the connections between b...
Show More Location
National Institutes of Health Clinical Center
Learn More & Join Trial
Decreasing Medication Errors by Caregivers Using a Health Literacy Intervention NA Giving medications to children can be confusing; studies have shown that ca...
Show More Location
Columbia University Medical Center
Learn More & Join Trial
Effect of Gabapentin on Postoperative Morphine Consumption After Sleeve Gastrectomy PHASE2 The evidence regarding effects of pain modulator like gabapentin on postope...
Show More Location
Multiple Locations
Learn More & Join Trial
Ceftolozane-Tazobactam for Directed Treatment of Pseudomonas Aeruginosa Bacteremia and Pneumonia in Patients With Hematological Malignancies and Hematopoietic Stem Cell Transplantation PHASE4 The goal of this clinical trial is to learn whether the antibiotic ceftoloz...
Show More Location
Weill Cornell Medicine
Learn More & Join Trial
Safety and Efficacy of Aliskiren in Pediatric Hypertensive Patients 6-17 Years of Age PHASE3 This double-blind 8 week study will evaluate dose response, efficacy (blood...
Show More Location
Novartis Investigative Site
Learn More & Join Trial
Early Rising PSA Endocrine Treatment Versus Chemo-endocrine Therapy- SPCG14 PHASE3 Summary
In patients with prostate cancer (PC) who have only biochemically ...
Show More Location
Copenhagen University hospital, Rigshospitalet
Learn More & Join Trial